Health Jul 01 Some health experts criticize U.S. mass purchase of licensed virus drug The U.S. government announced this week that it had an agreement with Gilead Sciences to make the bulk of their production of remdesivir available to Americans for the next three months. By Maria Cheng, Associated Press, Marilynn Marchione, AP Chief Medical Writer
Health Apr 30 Critical study of Gilead drug shows coronavirus patients responding to treatment, NIH says Gilead said a government-run study of remdesivir, perhaps the most closely watched experimental drug to treat Covid-19, showed the medicine is effective. By Matthew Herper, Adam Feuerstein, STAT News
Health May 14 What Trump’s PrEP deal means for the spread of HIV The Trump administration’s new deal to provide uninsured Americans with free drugs to prevent HIV infection could be a promising step, but actually reaching the very people most in need -- and convincing them to take it -- will be… By Jason Kane
Health Dec 01 Maker of $1,000 hepatitis C pill was focused on profits, not patients, report finds WASHINGTON — A bipartisan investigation by U.S. senators finds that the makers of a breakthrough drug for hepatitis C infection put profits before patients in pricing the $1,000-per-pill cure. By Ricardo Alonso-Zaldivar, Associated Press